- Report
- February 2023
- 220 Pages
Global
From €5393EUR$6,000USD£4,730GBP
€6741EUR$7,500USD£5,912GBP
- Report
- February 2022
- 220 Pages
Global
From €6831EUR$7,600USD£5,991GBP
€8539EUR$9,500USD£7,488GBP
- Report
- July 2024
- 105 Pages
Global
From €4269EUR$4,750USD£3,744GBP
- Report
- May 2024
- 130 Pages
Global
From €4965EUR$5,524USD£4,354GBP
€5841EUR$6,499USD£5,123GBP
- Report
- May 2024
- 133 Pages
Global
From €4965EUR$5,524USD£4,354GBP
€5841EUR$6,499USD£5,123GBP
- Report
- May 2024
- 128 Pages
Global
From €4965EUR$5,524USD£4,354GBP
€5841EUR$6,499USD£5,123GBP
- Report
- August 2023
- 75 Pages
Israel
From €3146EUR$3,500USD£2,759GBP
- Drug Pipelines
- June 2022
- 101 Pages
Global
From €13478EUR$14,995USD£11,820GBP
- Report
- October 2025
- 105 Pages
Global
From €3500EUR$4,171USD£3,177GBP
- Report
- November 2025
- 50 Pages
Global
From €2382EUR$2,650USD£2,089GBP
- Report
- March 2025
- 109 Pages
China
From €1618EUR$1,800USD£1,419GBP
- Report
- March 2025
- 215 Pages
China
From €3595EUR$4,000USD£3,153GBP
Valsartan is a drug used to treat high blood pressure and congestive heart failure. It belongs to a class of drugs known as angiotensin receptor blockers (ARBs). Valsartan works by blocking the action of a hormone called angiotensin II, which causes blood vessels to narrow and increases blood pressure. By blocking the action of angiotensin II, valsartan helps to relax the blood vessels and reduce blood pressure. It is also used to reduce the risk of stroke and heart attack in people with heart disease.
Valsartan is a widely used drug in the cardiovascular drug market. It is used to treat a variety of conditions, including hypertension, congestive heart failure, and coronary artery disease. It is also used to reduce the risk of stroke and heart attack in people with heart disease. Valsartan is available in both generic and branded forms, and is available in a variety of dosages.
Some companies in the valsartan market include Novartis, Teva Pharmaceuticals, Mylan, and Sandoz. Show Less Read more
